Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcγRI, FcγRIII, and FcγRIV

Despite the demonstrated clinical efficacy of CD20 monoclonal antibody (mAb) for lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and variable. To identify the molecular mechanisms responsible for lymphoma killing by CD20 mAb in a homologous system amenable to mechani...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Minard-Colin, Veronique, Xiu, Yan, Poe, Jonathan C., Horikawa, Mayuka, Magro, Cynthia M., Hamaguchi, Yasuhito, Haas, Karen M., Tedder, Thomas F.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2008
Matèries:
Immunobiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2515149/
https://ncbi.nlm.nih.gov/pubmed/18495955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-01-135160
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars